Zepp Health Corporation Stock Price, News & Analysis
Company Description
Zepp Health Corporation (NYSE: ZEPP) is a global smart wearable and health technology company. Through its consumer brands Amazfit, Zepp Clarity and Zepp Aura, the company focuses on helping users optimize their health, fitness and wellness journeys. Zepp Health is classified in the Electromedical and Electrotherapeutic Apparatus Manufacturing industry within the manufacturing sector and has shipped smart wearable products to users in many countries and regions worldwide.
According to the company, Zepp Health is powered by its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors and data algorithms. This platform delivers cloud-based, 24/7 insights and guidance to users of its smart devices. Zepp Health states that its products are available in more than 90 countries and regions and that it has shipped over 200 million units since its founding.
Zepp Health’s principal office is based in Gorinchem, the Netherlands, and it operates as a distributed organization with team members and offices across the Americas, Europe, Asia and other global markets. The company was originally founded as Huami Corp. in 2013 and later changed its name to Zepp Health Corporation in February 2021 to emphasize its health focus and to adopt a name that resonates across languages and cultures.
Amazfit: Smart Wearables and Sports Technology
Amazfit is described as a global smart wearable and fitness leader and is part of Zepp Health. Amazfit focuses on health and fitness-oriented smart wearables designed around movement, including training, recovery and long-term progress. The brand’s tagline, “Discover Amazing,” reflects its positioning around encouraging individuals to break barriers and find enjoyment in activity.
Amazfit offers a selection of smartwatches and fitness bands. The company’s disclosures and news highlight multiple product families and devices, including the Active family, the T-Rex series, Balance 2, Active 2, Helio Strap, Helio Ring and Helio Armband. These products are used by everyday users and by elite athletes in areas such as trail running, HYROX functional fitness racing, endurance sports and outdoor adventures. Amazfit devices are used to track metrics such as heart rate, sleep, training load, recovery indicators and other health-related data, which are then processed through the Zepp platform.
Amazfit smartwatches have received design recognition, including iF Design Award and Red Dot Design Award honors. Launched in 2015, the Amazfit brand is described as being embraced by millions of users, with products available in over 90 countries across the Americas, EMEA and APAC regions.
Amazfit Product Ecosystem and Athlete Partnerships
Zepp Health emphasizes an ecosystem-first approach for Amazfit. Devices such as the T-Rex 3 Pro, Active Max, Helio Strap, Helio Ring and Helio Armband are designed to work together and connect with the Zepp App, where users can view health, fitness, training and sleep data in one place. Company communications describe features such as advanced GPS, training tools, BioCharge energy monitoring, and integrations with third-party platforms like Strava and TrainingPeaks as part of this broader ecosystem.
Amazfit collaborates with a roster of elite athletes and brand ambassadors, including trail and ultra runners, HYROX competitors, Olympic medalists and other endurance athletes. These athletes use Amazfit devices in training and competition and provide feedback that Zepp Health uses in product development and refinement. The company highlights partnerships with events such as HYROX and UTMB race week as part of its engagement with performance sports communities.
Zepp Clarity and Hearing Health
Beyond smartwatches and fitness bands, Zepp Health is expanding its health technology ecosystem through Zepp Clarity, which offers over-the-counter hearing aids for individuals with mild-to-moderate hearing loss. Company news mentions models such as Zepp Clarity One, Pixie and Omni, which are described as combining discreet design, customizable sound, intuitive self-fitting and optional Bluetooth connectivity. Zepp Clarity hearing aids are distributed through direct-to-consumer channels and retail partners, including Target, Best Buy and Amazon, and Zepp Health notes that it is actively expanding its distribution partner network.
Wild.AI Acquisition and Female Athlete Focus
Zepp Health has also expanded its software and data capabilities through the acquisition of the core assets and intellectual property of Wild.AI, a women’s wellness platform focused on hormone-informed coaching. Wild.AI uses physiological and hormonal data to help women track, train, fuel and recover based on their menstrual cycle and life stage, including perimenopause and menopause. The platform offers training, nutrition and recovery guidance and integrates with wearables such as Amazfit, Garmin and Apple Watch.
Zepp Health’s integration of Wild.AI is aimed at deepening its support for female athletes across life stages. The company has indicated that it will continue to support the existing Wild.AI app, maintain compatibility with third-party wearables and roll out Wild.AI features across Amazfit devices, starting in the United States. This reflects Zepp Health’s focus on physiology-informed tools and hormone-aware coaching within its broader performance ecosystem.
Business Model and Industry Positioning
Within the Electromedical and Electrotherapeutic Apparatus Manufacturing industry, Zepp Health positions itself as a smart wearable and health technology company that combines hardware, software and data analytics. Its revenue-generating activities, as described in public information, center on the development, manufacturing and sale of smart wearable devices and hearing aids under its consumer brands, along with the associated health and wellness software experiences delivered through the Zepp platform.
The company’s communications highlight a diversified product portfolio across performance-focused sports watches, everyday fitness devices, hearing aids and hormone-informed wellness tools. Zepp Health’s platform approach, which includes AI chips, biometric sensors and data algorithms, is designed to provide continuous, cloud-based insights and coaching for users seeking to improve health, fitness and wellness outcomes.
Stock Information and Corporate Structure
Zepp Health Corporation’s American depositary shares, each representing sixteen Class A ordinary shares, trade on the New York Stock Exchange under the symbol ZEPP. The company files reports with the U.S. Securities and Exchange Commission as a foreign private issuer, including Form 20-F annual reports and Form 6-K current reports. Recent Form 6-K filings reference press releases and confirm Zepp Health Corporation as the registrant.
Zepp Health describes itself as a global organization with team members and offices across multiple regions. The company’s principal office is in Gorinchem, the Netherlands, and it notes particular presence in Europe and the USA. Its history as Huami Corp., its subsequent rebranding to Zepp Health Corporation, and its long-term focus on health technology form the core of its corporate identity.
FAQs
Stock Performance
Zepp Health Corporation (ZEPP) stock last traded at $13.41, down 4.35% from the previous close. Over the past 12 months, the stock has gained 269.4%, ranking #12 in 52-week price change. At a market capitalization of $201.3M, ZEPP is classified as a micro-cap stock with approximately 14.4M shares outstanding.
Latest News
Zepp Health Corporation has 10 recent news articles, with the latest published 5 days ago. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include earnings, earnings date, conferences. View all ZEPP news →
SEC Filings
Zepp Health Corporation has filed 5 recent SEC filings, including 5 Form 3. The most recent filing was submitted on March 17, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ZEPP SEC filings →
Financial Highlights
Zepp Health Corporation generated $182.6M in revenue over the trailing twelve months, retaining a 38.5% gross margin, operating income reached -$47.3M (-25.9% operating margin), and net income was -$75.7M, reflecting a -41.5% net profit margin. Diluted earnings per share stood at $-0.29. The company generated -$24.4M in operating cash flow. With a current ratio of 1.29, the company maintains adequate short-term liquidity.
Upcoming Events
Helio Glasses potential release
Zepp Health Corporation has 1 upcoming scheduled event. The next event, "Helio Glasses potential release", is scheduled for July 1, 2026 (in 102 days). Investors can track these dates to stay informed about potential catalysts that may affect the ZEPP stock price.
Short Interest History
Short interest in Zepp Health Corporation (ZEPP) currently stands at 357.8 thousand shares, down 31.2% from the previous reporting period, representing 2.6% of the float. Over the past 12 months, short interest has increased by 7221.7%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Zepp Health Corporation (ZEPP) currently stands at 3.0 days, down 18.2% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 201% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 3.7 days.
ZEPP Company Profile & Sector Positioning
Zepp Health Corporation (ZEPP) operates in the Consumer Electronics industry within the broader Technology sector and is listed on the NYSE. In monthly performance, the stock ranks #2,056 among all tracked companies.
Investors comparing ZEPP often look at related companies in the same sector, including Gopro Inc (GPRO), Sonos (SONO), Vuzix (VUZI), Lg Display (LPL), and Utime Ltd (WTO). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ZEPP's relative position within its industry.